INSIGHTS ON CLINICAL TRIAL DESIGN

• Vendor Selection Bias: Why Structured Decisions Often Fail

  Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

• Use Data For Fit-For-Purpose Patient Recruitment Strategy

  Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.

• Breaking Down Operational And Financial Complexity In Clinical Trials

  Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.

• From Chaos To Clarity: A Founder's View From 30 Years In Drug Development

  Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.

• Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems

  10/7/2025

  Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.

• What Clinical Trial Management Solutions Don't Cover: The Ocular Endpoint Execution Gap

  6/9/2026

  Discover how specialized endpoint execution closes critical gaps in ophthalmic trials, improving assessment consistency, protocol adherence, data quality, and participant retention.

• How Mobile Clinics Advance Diversity In Clinical Research

  12/4/2025

  Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.

• Evaluating Adaptive Trials: Do They Align With Your Study's Goals?

  4/10/2025

  In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.

• How To Accelerate Early-Phase Oncology Trial

  5/12/2026

  Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.